Frontlight ResearchEarly access
Familial hypercholesterolaemia trials in Malaysia
5 of 5 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in MalaysiaA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients
- Where
- Ampang, Beseri, Kuala Kedah, Puchong, Sarawak Miri
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07930507 - No phaseTaking peopleGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Kuala Lumpur, Shah Alam
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - Phase 3Active, not recruitingLong-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Where
- Kuala Lumpur, Sungai Buloh
- Age
- 2 years to 100 years
- People
- 195 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05682378 - Phase 3Taking peopleStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Where
- Kota Bharu
- Age
- 2 years to 11 years
- People
- 9 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597006 - Phase 3Taking peopleStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Where
- Kuala Lumpur
- Age
- 6 years to 11 years
- People
- 60 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06597019